drugset

drugset / Trial / NCT06354114

A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011

NCT06354114 ↗

Phase 2 Not yet recruiting 80 enrolled CSPC Ouyi Pharmaceutical Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this study is to evaluate the efficacy and safety in subjects with advanced breast cancer treated with SYHX2011

Timeline

Start: 2024-04
Primary completion: 2024-10-31
Completion: 2026-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SYHX2011	Unknown	260 mg/m2	Intravenous

Indications